<DOC>
	<DOCNO>NCT00291954</DOCNO>
	<brief_summary>Hepatitis B prevention non-responders uraemic patient currently base HBsAg surveillance isolation HBsAg carrier . A immunogenic vaccine would benefit population .</brief_summary>
	<brief_title>Compare Immune Response &amp; Safety Elicited Henogen 's Adjuvanted Hepatitis B Vaccine v Aventis Pasteur MSD 's Hepatitis B Vaccine Pre-Dialysis &amp; Dialysis Patients Who Did Not Respond Previous Hepatitis B Vaccination</brief_title>
	<detailed_description>Study participant receive either Henogen 's adjuvanted hepatitis B vaccine Aventis Pasteur 's hepatitis B vaccine . The study involve total 4 visit blood sample take visit .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Inclusion criteria A male female subject great equal 15 year age time study entry Written inform consent obtain subject/ parent guardian subject . Seronegative antiHBc antibody HBsAg screening . Predialysis patient , peritoneal dialysis patient haemodialysis patient Documented evidence previous hepatitis B vaccination least one full primary vaccination course minimum four injection license vaccine . The last dose administer least two month plan first dose study vaccine study . Documented evidence nonresponse previous hepatitis B vaccination least one maximum three month last vaccine dose . Exclusion criterion Subject include HN014/HBV001 study . History Hepatitis B infection Use immunoglobulin within six month precede first study vaccination . Any confirm suspected human immunodeficiency virus ( HIV ) infection . Pregnant lactate female</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Dialysis</keyword>
	<keyword>Pre-dialysis</keyword>
	<keyword>Hepatitis B vaccine</keyword>
	<keyword>Prophylaxis hepatitis B infection</keyword>
</DOC>